Analysis of myopathy in a placebo-controlled zidovudine trial

Muscle Nerve. 1997 Mar;20(3):382-5. doi: 10.1002/(SICI)1097-4598(199703)20:3<382::AID-MUS22>3.0.CO;2-1.

Authors

D M Simpson¹, P Slasor, U Dafni, J Berger, M A Fischl, C Hall

Affiliation

¹ Department of Neurology, Mount Sinai Medical Center, New York, New York 10029, USA.

PMID: 9052824
DOI: 10.1002/(SICI)1097-4598(199703)20:3<382::AID-MUS22>3.0.CO;2-1

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Acquired Immunodeficiency Syndrome / complications*
Acquired Immunodeficiency Syndrome / drug therapy*
Creatine Kinase / blood
Dose-Response Relationship, Drug
Humans
Muscular Diseases / chemically induced*
Muscular Diseases / complications*
Placebos
Zidovudine / administration & dosage
Zidovudine / adverse effects*
Zidovudine / therapeutic use

Substances

Placebos
Zidovudine
Creatine Kinase